Efficient Eradication of Bacterial Biofilms with Highly Specific Graphene-Based Nanocomposite Sheets
Source abstract
Abstract
Bacterial biofilms are usually resistant to antibiotics, thus powerful methods are required for removal. Nanomaterial involving a combination of treatment modalities recently has been recognized as an effective alternative to combat biofilm. However, its targeted and controlled release in bacterial infection is still a major challenge. Here, we present an intelligent phototherapeutic nanoplatform consisting of an aptamer (Apt), indocyanine green (ICG), and carboxyl-functionalized graphene oxide (GO–COOH), namely, ICG@GO-Apt, for targeted treatment of the biofilm formed by Salmonella Typhimurium. Since Apt-conjugated nanosheets (NSs) can specifically accumulate near abscess caused by the pathogens, they enhance greatly the local drug molecule concentration and promote their precise delivery. They can simultaneously generate heat and reactive oxygen species under near-infrared irradiation for photothermal/photodynamic therapy, thereby significantly enhancing biofilm elimination. The phototherapeutic ICG@GO-Apt also displays a good biocompatibility. More importantly, the multifunction phototherapeutic platform shows an efficient biofilm elimination with an efficiency of greater than 99.99% in an abscess formation model. Therefore, ICG@GO-Apt NSs with bacteria-targeting capability provide a reliable tool for clinical bacterial infection that circumvents antibiotic resistance.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Graphene and Nanomaterials Applications · Nanoplatforms for cancer theranostics · Advanced biosensing and bioanalysis techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Developmental Biology of Freshwater Fish, Hunan Normal University, Changsha 410081, Hunan, People’s Republic of China
Department of Respiratory Diseases, Medical School, Hunan University of Chinese Medicine, Changsha 410208, Hunan, People’s Republic of China
Changsha Customs Technology Center, Xiangfu middle Road 188, Changsha, Hunan 410004, People’s Republic of China
Funding
National Natural Science Foundation of China · Changsha Municipal Natural Science Foundation
References (42)
Show source-provided references
1. Humphreys, G.; Fleck, F. United Nations Meeting on Antimicrobial Resistance; World Health Organization, 2016; Vol. 94, pp 638–639.10.2471/BLT.16.020916 ↗
2. 10.1016/j.chom.2019.11.01110.1016/j.chom.2019.11.011 ↗
3. 10.1080/14787210.2018.141703610.1080/14787210.2018.1417036 ↗
4. 10.1146/annurev.micro.54.1.4910.1146/annurev.micro.54.1.49 ↗
5. 10.2217/fmb.15.6910.2217/fmb.15.69 ↗
6. 10.4155/fmc.15.610.4155/fmc.15.6 ↗
7. 10.1021/acsnano.7b0473110.1021/acsnano.7b04731 ↗
8. 10.1021/acsnano.9b0549310.1021/acsnano.9b05493 ↗
9. 10.1021/acs.chemmater.0c0205510.1021/acs.chemmater.0c02055 ↗
10. 10.1021/acs.jmedchem.0c0085610.1021/acs.jmedchem.0c00856 ↗
11. 10.1021/acs.bioconjchem.9b0082110.1021/acs.bioconjchem.9b00821 ↗
12. 10.1021/acs.jmedchem.9b0112010.1021/acs.jmedchem.9b01120 ↗
13. 10.1038/s41579-018-0141-x10.1038/s41579-018-0141-x ↗
14. 10.1093/femspd/ftv03410.1093/femspd/ftv034 ↗
15. 10.1021/acs.langmuir.8b0199510.1021/acs.langmuir.8b01995 ↗
16. 10.1016/j.colsurfb.2017.11.06010.1016/j.colsurfb.2017.11.060 ↗
17. 10.1021/acsami.8b0132710.1021/acsami.8b01327 ↗
18. 10.1016/j.ejmech.2019.01.00710.1016/j.ejmech.2019.01.007 ↗
19. 10.1002/adfm.20170197410.1002/adfm.201701974 ↗
20. 10.1002/bab.163110.1002/bab.1631 ↗
21. 10.1007/s10482-017-0941-410.1007/s10482-017-0941-4 ↗
22. 10.1080/1061186X.2018.149197810.1080/1061186X.2018.1491978 ↗
23. 10.1016/j.biochi.2017.09.01410.1016/j.biochi.2017.09.014 ↗
24. 10.1039/C5CS00645G10.1039/C5CS00645G ↗
25. 10.1016/j.addr.2018.08.00510.1016/j.addr.2018.08.005 ↗
26. 10.1016/j.coph.2010.06.00910.1016/j.coph.2010.06.009 ↗
27. 10.2334/josnusd.17-020310.2334/josnusd.17-0203 ↗
28. 10.1016/j.ijmm.2018.11.00210.1016/j.ijmm.2018.11.002 ↗
29. 10.2147/IJN.S21280710.2147/IJN.S212807 ↗
30. 10.1016/j.jconrel.2020.08.05510.1016/j.jconrel.2020.08.055 ↗
31. 10.1021/acsami.9b0703710.1021/acsami.9b07037 ↗
32. 10.1016/j.pdpdt.2016.10.00610.1016/j.pdpdt.2016.10.006 ↗
33. 10.1039/D0NR01208D10.1039/D0NR01208D ↗
34. 10.1021/acsami.8b0318510.1021/acsami.8b03185 ↗
35. 10.1021/acs.molpharmaceut.9b0011910.1021/acs.molpharmaceut.9b00119 ↗
36. 10.1007/s12274-008-8021-810.1007/s12274-008-8021-8 ↗
37. 10.1039/D0BM00821D10.1039/D0BM00821D ↗
38. 10.1002/(SICI)1099-1409(199803/04)2:2<145::AID-JPP60>3.0.CO;2-210.1002/(SICI)1099-1409(199803/04)2:2<145::AID-JPP60>3.0.CO;2-2 ↗
39. 10.1021/acsnano.9b0987110.1021/acsnano.9b09871 ↗
40. 10.3389/fmicb.2020.0169510.3389/fmicb.2020.01695 ↗
41. 10.1021/acsami.9b1009610.1021/acsami.9b10096 ↗
42. 10.1021/acs.nanolett.9b0140010.1021/acs.nanolett.9b01400 ↗